Merck (MRK) Other Working Capital Changes (2009 - 2026)

Merck (MRK) reported Other Working Capital Changes of $1.6 billion for Q1 2026, down 56.55% year-over-year from $3.7 billion in Q1 2025, and up 219.48% quarter-over-quarter from -$1.4 billion in Q4 2025.

Merck (MRK) Other Working Capital Changes (2009 - 2026) Analysis & Trends

Merck (MRK) has 18 years of Other Working Capital Changes data on file, last reported at $1.6 billion in Q1 2026.

  • Other Working Capital Changes for Q1 2026 came in at $1.6 billion, down 56.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (down 30.81% YoY), and the FY2025 annual result was $3.3 billion, up 133.55% from the prior year.
  • Other Working Capital Changes improved to $1.6 billion in Q1 2026 per MRK's latest filing, from -$1.4 billion in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $3.7 billion in Q1 2025 and troughed at -$2.6 billion in Q3 2024.
  • A 5-year average of $595.5 million and a median of $1.0 billion in 2024 frame the typical range for Other Working Capital Changes.
  • The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes slumped 1031.43% in 2024, then jumped 123.22% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at -$962.0 million in 2022, then soared by 96.36% to -$35.0 million in 2023, then tumbled by 1031.43% to -$396.0 million in 2024, then sank by 240.91% to -$1.4 billion in 2025, then surged by 219.48% to $1.6 billion in 2026.
  • Business Quant data shows MRK's Other Working Capital Changes at $1.6 billion in Q1 2026, -$1.4 billion in Q4 2025, and -$1.3 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.61 Bn
Mar 31, 2026 1.61 Bn
Dec 31, 2025 -1.35 Bn
Dec 31, 2025 -1.35 Bn
Sep 30, 2025 -1.31 Bn
Sep 30, 2025 -1.31 Bn
Jun 30, 2025 2.26 Bn
Jun 30, 2025 2.26 Bn
Mar 31, 2025 3.71 Bn
Mar 31, 2025 3.71 Bn
Dec 31, 2024 -396.00 Mn
Dec 31, 2024 -396.00 Mn
Sep 30, 2024 -2.58 Bn
Sep 30, 2024 -2.58 Bn
Jun 30, 2024 1.01 Bn
Jun 30, 2024 1.01 Bn
Mar 31, 2024 3.38 Bn
Mar 31, 2024 3.38 Bn
Dec 31, 2023 -35.00 Mn
Dec 31, 2023 -35.00 Mn